NS Pharma Inc, a wholly owned subsidiary of Nippon Shinyaku Co Ltd, launches NS Support for patients with Duchenne muscular dystrophy (DMD) and their healthcare providers.
NS Support can be reached by telephone at 833-677-8778, Monday through Friday from 8 am to 8 pm ET. Caregivers and healthcare providers can call to learn more information about NS Support and request notifications about product availability and program enrollment.
Related Content:
Team Joseph and Duchenne Community Unite to Help Families During COVID-19
Gene Therapy Trial in Duchenne Kids Suggests Functional Improvement Gains
Submit Your Ideas for the CureDuchenne Pitch Contest Until July 13
“Based on our conversations with the DMD community, there is a high demand for assistance with navigating the complicated insurance landscape for DMD patients amenable to exon 53 skipping therapy,” said Tsugio Tanaka, President, NS Pharma Inc, in a media release.
“We want to ensure the smoothest patient experience possible and a rapid journey towards access and treatment. That is why we are launching NS Support now, so we can begin the process of engaging with families who want to learn more about what NS Support can offer.”
For more information, visit NS Pharma Inc.
[Source(S): NS Pharma Inc, PR Newswire]
